Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071998
Filing Date
2025-05-15
Accepted
2025-05-15 07:45:33
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pvla-20250331.htm   iXBRL 10-Q 1517668
2 EX-31.1 pvla-ex31_1.htm EX-31.1 17594
3 EX-31.2 pvla-ex31_2.htm EX-31.2 17600
4 EX-32.1 pvla-ex32_1.htm EX-32.1 11407
5 EX-32.2 pvla-ex32_2.htm EX-32.2 10889
  Complete submission text file 0000950170-25-071998.txt   6640117

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pvla-20250331.xsd EX-101.SCH 978491
59 EXTRACTED XBRL INSTANCE DOCUMENT pvla-20250331_htm.xml XML 1106670
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 25948752
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)